Hepatic manifestations of Wilson's disease: 12-year experience in a Swiss tertiary referral centre

Inflammatory Bowel Disease

Hepatobiliary and pancreatic manifestations in inflammatory bowel diseases: a referral center study

BMC Gastroenterol.

Fousekis FS, Katsanos KH, Theopistos VI, Baltayiannis G, Kosmidou M, Glantzounis G, Christou L, Tsianos EV, Christodoulou DK

doi: 10.1186/s12876-019-0967-3.

Inflammatory Bowel Disease

Occurrence of skin manifestations in patients of the Swiss Inflammatory Bowel Disease Cohort Study

PLoS One.

Roth N, Biedermann L, Fournier N, Butter M, Vavricka SR, Navarini AA, Rogler G, Scharl M; Swiss IBD Cohort Study Group

doi: 10.1371/journal.pone.0210436.

Inflammatory Bowel Disease

Causes and Prognosis of Intestinal Failure in Crohn's Disease: An 18-year Experience from a National Centre

J Crohns Colitis.

Soop M, Khan H, Nixon E, Teubner A, Abraham A, Carlson G, Lal S

doi: 10.1093/ecco-jcc/jjaa060.

Inflammatory Bowel Disease

Effect of distance to specialist care for the diagnosis and disease outcome of inflammatory bowel disease in the Swiss inflammatory bowel disease cohort study

Therap Adv Gastroenterol.

Grob L, Bluemel S, Biedermann L, Fournier N, Rossel JB, Vavricka SR, Zeitz J, Rogler G, Stallmach A, Scharl M

doi: 10.1177/1756284819895217.

RECOMMENDED

Inflammatory Bowel Disease

Uveitis manifestations in patients of the Swiss Inflammatory Bowel Disease Cohort Study

Therap Adv Gastroenterol.

Biedermann L, Renz L, Fournier N, Rossel JB, Butter M, Bluemel S, Vavricka SR, Rogler G, Scharl M

doi: 10.1177/1756284819865142.

Inflammatory Bowel Disease

"Long-term efficacy and safety of Vedolizumab in Inflammatory Bowel Diseases patients: a real-life experience from a Tertiary Referral Center"

J Dig Dis.

Dragoni G, Bagnoli S, Le Grazie M, Campani C, Rogai F, Manetti N, Bensi C, Macri' G, Galli A, Milla M

doi: 10.1111/1751-2980.

Hepatology

Wilson's disease or hepatolenticular degeneration

Ther Umsch.

Mensing B, Nowak A, Zweifel S, Terracciano L, Bernsmeier C, Filipowicz Sinnreich M

doi: 10.1024/0040-5930/a000995.

Inflammatory Bowel Disease

Lower Risk of B1-to-pB3-Stage Migration in Crohn's Disease Upon Immunosuppressive and Anti-TNF Treatment in the Swiss IBD Cohort Study

Dig Dis Sci.

Cernoch PS, Fournier N, Zeitz J, Scharl M, Morell B, Greuter T, Schreiner P, Misselwitz B, Safroneeva E, Schoepfer AM, Vavricka SR, Rogler G, Biedermann L, Swiss IBD Cohort Study Group.

doi: 10.1007/s10620-019-05978-9.

Gastrointestinal DiseasesInflammatory Bowel Disease

The impact of colectomy on the course of extraintestinal manifestations in Swiss inflammatory bowel disease cohort study patients

United European Gastroenterol J

Roth R, Vavricka S, Scharl M, Schreiner P, Safroneeva E, Greuter T, Zeitz J, Misselwitz B, Schoepfer A, Barry MP, Rogler G, Biedermann L, Swiss IBD cohort study.

doi: 10.1002/ueg2.12125

Related content

Hepatobiliary and pancreatic manifestations in inflammatory bowel diseases: a referral center study

Occurrence of skin manifestations in patients of the Swiss Inflammatory Bowel Disease Cohort Study

Causes and Prognosis of Intestinal Failure in Crohn's Disease: An 18-year Experience from a National Centre

Effect of distance to specialist care for the diagnosis and disease outcome of inflammatory bowel disease in the Swiss inflammatory bowel disease cohort study

Uveitis manifestations in patients of the Swiss Inflammatory Bowel Disease Cohort Study

"Long-term efficacy and safety of Vedolizumab in Inflammatory Bowel Diseases patients: a real-life experience from a Tertiary Referral Center"

Wilson's disease or hepatolenticular degeneration

Lower Risk of B1-to-pB3-Stage Migration in Crohn's Disease Upon Immunosuppressive and Anti-TNF Treatment in the Swiss IBD Cohort Study

The impact of colectomy on the course of extraintestinal manifestations in Swiss inflammatory bowel disease cohort study patients